Evaluating the safety and effectiveness of Onyx stents in elderly patients with coronary artery disease
Official title: Safety and Efficacy of 1-month Dual Antiplatelet Therapy in High Bleeding and Ischemic Risk Elderly Patients With Coronary Artery Disease After Implantation of Zotarolimus-eluting Coronary Stent System (Onyx Family, Medtronic, Minneapolis, MN); A Multicenter, Prospective, Observational Study
Run by Pusan National University Yangsan Hospital · NCT06577896 · Data updated 2026-11-12
This study is testing if switching from two blood-thinning medications to one after using Onyx stents helps elderly patients with heart disease stay safe and healthy over a year.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 75 Years to 100 Years |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Pusan National University Yangsan Hospital Academic / other |
| Locations | 1 site (Yangsan, Gyeongsangnam-do) |
| Status | Recruiting |
| Started | June 9, 2022 |
| Main results expected | January 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | September 19, 2024 |
| Trial ID | NCT06577896 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are elderly patients aged 75 years or older who have undergone coronary artery procedures with Onyx family stents and are able to take antiplatelet medications.
✕Probably not a fit
Patients with known hypersensitivity to antiplatelet medications or those with active bleeding conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on elderly patients aged 75 years or older who are undergoing percutaneous coronary intervention with Onyx family drug-eluting stents. It aims to observe the safety and efficacy of transitioning from dual antiplatelet therapy to single therapy after one month of dual therapy. The study will monitor these patients for one year following the procedure to assess outcomes related to myocardial ischemia and coronary artery stenosis. The goal is to determine the best antiplatelet strategy for this vulnerable population.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment protocols for elderly patients with coronary artery disease, potentially reducing the risk of complications associated with prolonged dual antiplatelet therapy.
How similar studies have gone: While there have been studies on dual antiplatelet therapy, this specific approach focusing on elderly patients with Onyx stents is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 75 or more. * Eligible for interventional procedures. * Evidence of myocardial ischemia or coronary artery stenosis ≥ 50%. * Able to take antiplatelets for at least 1 months after the procedure. * Patients who underwent coronary artery procedures with ZES (Medtronic, Minneapolis, MN, Onyx™ family) stent. Exclusion Criteria: * The patient has a known hypersensitivity or contraindication to any of the following medications: heparin, aspirin, clopidogrel, zotarolimus, and contrast media (patients with documented sensitivity to contrast media which can be effectively premedicated with steroids and diphenhydramine \[eg, rash\] may be enrolled. Those with true anaphylaxis to prior contrast media, however, should not be enrolled). * Patients with active pathologic bleeding. * Gastrointestinal or genitourinary bleeding within the prior 3 months, or major surgery within 2 months. * History of bleeding diathesis or known coagulopathy (including heparin-induced thrombocytopenia). * Noncardiac comorbid conditions are present with life expectancy \<1 year or that may result in protocol noncompliance (per site investigator\'s medical judgment). * Patients who are actively participating in another drug or device investigational study, which have not completed the primary endpoint follow-up period.
Where it's running
-
Pusan National University Yangsan Hospital
Yangsan, Gyeongsangnam-do, South Korea Recruiting
Study contacts
- Principal investigator: Min Ku Chon, MD,PhD — Pusan National University Yangsan Hospital
- Study coordinator: Min Ku Chon, MD,PhD
- Email: chonmingu@gmail.com
- Phone: 82-10-2562-6258
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease
This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.
-
Gastric Ultrasound Before CABG to See if Heart Function Changes Stomach Contents
This study checks whether people with weaker heart function before elective CABG have different stomach contents seen on ultrasound.
-
Can preoperative photon-counting CT help predict heart recovery after bypass surgery?
This observational study tests whether a preoperative photon-counting CT can help predict heart function 3 months after coronary bypass surgery in adults with coronary artery disease.
-
Real-World Drug-Coated Balloon Angioplasty in Coronary Artery Disease
This registry tests how drug-coated balloons perform in everyday clinical practice for adults with coronary artery disease undergoing PCI.
-
Predicting vasopressor needs after anesthesia in elective on-pump CABG using dynamic arterial elastance
This study tests whether EaDyn measured after induction can help predict which patients will need vasopressors during elective on-pump CABG.
-
Intraoperative Pulse Pressure Variation and Postoperative Lactate Clearance in CABG Patients
This study tests whether the amount a patient’s pulse pressure varies during surgery relates to how quickly lactate levels drop after CABG.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.